Rare diseases
Investigational molecules
Locations
3050 Science Park Road, 92121-1102, United States
Prometheus Biosciences Inc. is active in inflammatory bowel disease research with a focus on Crohn’s disease, including clinical programs examining symptom control, endoscopic improvement, and clinical remission outcomes.
The sponsor’s work in this area reflects a therapeutic interest in disease activity reduction and intestinal healing.
Prometheus Biosciences Inc. runs clinical trials in conditions such as Crohn's disease, Colitis ulcerative, Systemic sclerosis pulmonary, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Study on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
CzechiaTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
